To the best of our knowledge, our study was the first to demonstrate that aberrant interactions between abnormal α-Syn and SYT13 may lead to dysregulation of extracellular vesicle release in Lewy body diseases and MSA, as confirmed in post-mortem brain tissues. The gene discussed is SYT13; the disease is multiple system atrophy.